Rich in lutein, zeaxanthin, and beta-carotene - nutrients crucial for preserving good vision - cavolo nero - better known as ...

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...

We all want to keep our eyes healthy and our vision crisp. Some of your daily habits might be secretly sabotaging your efforts.

Joan Plowright was in the movie and theater world for decades before she retired, so what was her net worth ahead of her ...

Joan Plowright, perhaps the greatest Anglophone actor of the 20th century and the widow of Laurence Oliver, has died. She was ...

Outlook Therapeutics, Inc. (NASDAQ:OTLK) completed the analysis of the complete 12-week safety and efficacy results for NORSE ...

The trial evaluated ONS-5010 in wet age-related macular degeneration patients, and the company plans to resubmit a Biologics ...

Outlook (OTLK) stock fell 10% after the company said it had completed a study analysis for its drug ONS-5010 and entered into ...

The following is a summary of “Neuroretinal and RPE changes and susceptibility to Age-Related Macular Degeneration: insights ...

Retinal Biologics Industry. The retinal biologics market experienced significant growth in 2021, with total revenue reaching ...

Ocugen (OCGN) announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema, DME. “OCU200 has ...